Delivery Order SPE2DB20D3103-SPE2DB22FP6R8

Award Date 8/29/22
Potential Completion Date 8/30/22
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The contract has a ceiling value of $6,822.50 and a completion date of February 27, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $2,702.70 and a completion date of March 18, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a diabetes management medication, with a ceiling value of $4,556.83 and an ultimate completion date of May 12, 2023. The contract is a firm fixed-price delivery order with no set-aside requirements, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The contract has a ceiling value of $4,079.38 and an ultimate completion date of May 1, 2023. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen also holds a significant...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to treat diabetes. The Delivery Order has a ceiling value of $6,651.53 and a period of performance through July 23, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of Trulicity 4.5 mg/0.5 mL pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $2,480.85 and runs through January 14, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used for diabetes management. The contract is a firm fixed-price delivery order with a ceiling value of $1,741.62 and a period of performance through March 4, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 4.5 mg/0.5 mL pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $1,374.88 and a completion date of January 30, 2023. The contract is a firm-fixed-price type contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the U.S. The contract is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. The contract has a ceiling value of $5,805.60 and is a firm-fixed price contract. It has an ultimate completion date of July 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used to manage diabetes. The contract has a ceiling value of $4,193.74 and an ultimate completion date of July 24, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FP6R8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Trulicity 4.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $3,659.04 and an ultimate completion date of August 30, 2022. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:46 AM